📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). (2021)

First Author: Brennan PN

Attributed to: Autologous Macrophage Therapy for Liver Cirrhosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-053190

PubMed Identifier: 34750149

Publication URI: http://europepmc.org/abstract/MED/34750149

Type: Journal Article/Review

Volume: 11

Parent Publication: BMJ open

Issue: 11

ISSN: 2044-6055